Company profile
Sigyn Therapeutics, Inc. CIK 1642159
Ticker
SIGY (OTC)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Beverly Hills, CA 90212
Fiscal year end
2024 (FY)
Key Financials
Revenue
—
Net income
-$3.34M
Total assets
$213.7K
Total liabilities
$4.67M
Stockholders' equity
-$4.46M
Cash & equivalents
$12.1K
Operating income
-$2.52M
Operating cash flow
-$872.4K
Capital expenditures
—
Fiscal year 2024, via 10-K filed 2025-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
2,185.7%
Equity / assets
-2,085.7%
CapEx / revenue
—
Operating cash flow / net income
0.26×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
—
-$3.34M
$213.7K
$4.67M
-$4.46M
2023
—
-$4.15M
$321.8K
$3.73M
-$3.41M
2022
—
-$2.93M
$332.9K
$2.24M
-$1.90M
2021
—
-$3.00M
$710.3K
$974.8K
-$264.6K
2020
—
-$1.26M
$694.1K
$594.9K
$99.2K
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 15-12G
2026-07-16
Financials filed via
Form 10-K
filed 2025-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Beverly Hills, CA 90212
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.